Announce Date | 02/27/2025 |
EPS Normalized Actual | $-0.17195 (Miss by $-0.20195) |
EPS GAAP Actual | $-0.17195 (Miss by $-0.20195) |
Revenue Actual | $0.015083B |
Revenue Surprise | Beat by $15.083M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.05 |
EPS GAAP Estimate | $0.05 |
Revenue Estimate | $0.0188B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 0.45 | 8.84 | 0.41498 | 0.47983 | 1 |
Dec 2025 | -0.57 | -6.98 | -0.57 | -0.57 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.17 | -0.125 | 0.015083B | 33.24% | -1.12M |
FQ3 2024 (Sep 2024) | -0.16 | -0.095 | 0.016101B | 14.94% | 1.1M |
FQ1 2013 (Mar 2013) | -4.2 | -4.2 | 0.0051482B | 100% | 5.15M |
FQ2 2013 (Jun 2013) | -0.65 | -0.65 | 0.0074007B | 100% | 7.4M |
FQ1 2014 (Mar 2014) | 0.37 | 0.37 | 0.00636261B | 19.09% | 6.36M |
FQ2 2014 (Jun 2014) | 1.08 | 1.08 | 0.00676241B | -9.44% | 6.76M |
FQ2 2024 (Jun 2024) | -0.23 | -1.57259 | 0.015184B | -4.25% | -16.48M |
FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 0.014231B | -15.55% | 14.23M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.05
Consensus Revenue Estimates
0.0188B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.18 | -- | 0.16797 | 0.1866 | 1 |
FQ3 2026 (Sep 2026) | 0.17 | -- | 0.15864 | 0.17623 | 1 |
FQ2 2026 (Jun 2026) | 0.07 | -- | 0.06532172 | 0.07256551 | 1 |
FQ1 2026 (Mar 2026) | 0.03 | -- | 0.02799502 | 0.0310995 | 1 |
FQ4 2025 (Oct 2025) | 0.13 | 230.77 | 0.12892 | 0.13108 | 1 |
FQ3 2025 (Jul 2025) | 0.04 | 500 | 0.03966667 | 0.04033333 | 1 |
FQ2 2025 (Jun 2025) | 0.05 | 560 | 0.04947399 | 0.05052601 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ3 2026 (Sep 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ1 2026 (Mar 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ4 2025 (Oct 2025) | 0.02B | 28.18 | 0.02B | 0.02B | 0 |
FQ3 2025 (Jul 2025) | 0.02B | 14.36 | 0.02B | 0.02B | 0 |
FQ2 2025 (Jun 2025) | 0.02B | 19.23 | 0.02B | 0.02B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.045 | -0.17 | -0.125 | 73.53% |
FQ3 2024 (Sep 2024) | -0.065 | -0.16 | -0.095 | 59.38% |
FQ1 2013 (Mar 2013) | -4.2 | -4.2 | 100% | |
FQ2 2013 (Jun 2013) | -0.65 | -0.65 | 100% | |
FQ1 2014 (Mar 2014) | 0.37 | 0.37 | 100% | |
FQ2 2014 (Jun 2014) | 1.08 | 1.08 | 100% | |
FQ2 2024 (Jun 2024) | 1.34259 | -0.23 | -1.57259 | 683.73% |
FQ1 2024 (Mar 2024) | -0.23 | -0.23 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.02B | $0.02B | $-1.12M | -7.41% |
FQ3 2024 (Sep 2024) | $0.02B | $0.02B | $1.1M | 6.84% |
FQ1 2013 (Mar 2013) | $0B | $0.01B | $5.15M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.01B | $7.4M | 100% |
FQ1 2014 (Mar 2014) | $0B | $0.01B | $6.36M | 100% |
FQ2 2014 (Jun 2014) | $0B | $0.01B | $6.76M | 100% |
FQ2 2024 (Jun 2024) | $0.03B | $0.02B | $-16.48M | -108.51% |
FQ1 2024 (Mar 2024) | $0B | $0.01B | $14.23M | 100% |